Fraxamoside, identified by its CAS number 326594-34-7, is a chemical compound that belongs to the class of glycosides. It is characterized by its structural composition, which typically includes a sugar moiety linked to a non-sugar component, often contributing to its biological activity. Fraxamoside has garnered interest in pharmacological research due to its potential therapeutic properties, including anti-inflammatory and antioxidant effects. The compound is often studied for its role in various biological systems, particularly in relation to its interaction with cellular pathways. Its solubility, stability, and reactivity can vary based on environmental conditions and the presence of other substances. As with many glycosides, the specific characteristics of Fraxamoside, such as its melting point, boiling point, and spectral properties, are essential for understanding its behavior in chemical reactions and biological applications. Further research is ongoing to fully elucidate its mechanisms of action and potential uses in medicine and biotechnology.

Fraxamoside

326594-34-7: Fraxamoside, identified by its CAS number 326594-34-7, is a chemical compound that belongs to the class of glycosides. It is characterized by its structural composition, which typically includes a sugar moiety linked to a non-sugar component, often contributing to its biological activity. Fraxamoside has garnered interest in pharmacological research due to its potential therapeutic properties, including anti-inflammatory and antioxidant effects. The compound is often studied for its role in various biological systems, particularly in relation to its interaction with cellular pathways. Its solubility, stability, and reactivity can vary based on environmental conditions and the presence of other substances. As with many glycosides, the specific characteristics of Fraxamoside, such as its melting point, boiling point, and spectral properties, are essential for understanding its behavior in chemical reactions and biological applications. Further research is ongoing to fully elucidate its mechanisms of action and potential uses in medicine and biotechnology.

Fraxamoside is a xanthine oxidase inhibitor (XOI) comparable in potency in vitro to the standard antigout drug allopurinol.

<p>Fraxamoside is a natural compound, classified as a secoiridoid glycoside. It is derived primarily from plants in the Oleaceae family, such as Fraxinus chinensis, commonly known as ash trees. The mode of action of fraxamoside involves its ability to act as an antioxidant, scavenging free radicals and thereby reducing oxidative stress. Additionally, it exhibits anti-inflammatory properties, which can modulate immune responses by inhibiting pro-inflammatory mediators.</p>

CAS 326594-34-7

Fraxamoside

Fraxamoside

Ref: TM-TN4080

Fraxamoside

Ref: BP-SBP01705

Fraxamoside

Ref: 3D-BNA59434